Low-dose combined oral contraceptive and cervicovaginal shedding of human immunodeficiency virus

Contraception

Volumn 83, Issue 6, 2011, Pages 564-570

  Roccio, Marianna ^a   Gardella, Barbara ^a   Maserati, Renato ^a   Zara, Francesca ^a   Iacobone, Daniela ^a   Spinillo, Arsenio ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Cervicovaginal secretions; Heterosexual transmission; HIV shedding; Infections; Oral contraceptives

Indexed keywords

ACICLOVIR; ETHINYLESTRADIOL; LOW DOSE ORAL CONTRACEPTIVE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VAGINITIS; VIRUS LOAD;

ADULT; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; GENITALIA, FEMALE; HIV SEROPOSITIVITY; HUMANS; PROSPECTIVE STUDIES; RNA, VIRAL; SOCIOECONOMIC FACTORS; VIRUS SHEDDING; YOUNG ADULT;

EID: 79955942857     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.10.008     Document Type: Article

References (30)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS epidemic update: November 2009. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2009/ default.asp.
2. Mostad S, Overbaugh J, DeVange D, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997;350:922-7. (Pubitemid 27420529)
3. Prakash M, Kapembwa MS, Gotch F, Patterson S. Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4, cells in the cervical epithelium of healthy women. J Reprod Immunol 2002;54:117-31. (Pubitemid 34143096)
4. Kovacs A, Wasserman SS, Burns D, et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001;358:1593-601. (Pubitemid 33101909)
5. Fiore JR, Suligoi B, Saracino A, et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS 2003;17(15):2169-76. (Pubitemid 37338890)
6. Coleman JS, Hitti J, Bukusi EA, et al. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007;21: 755-9. (Pubitemid 46568633)
7. Spinillo A, Debiaggi M, Zara F, et al. Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervicovaginal secretions. BJOG 2001;108:634-41. (Pubitemid 33646506)
8. Andreoletti L, Chomont N, Gresenguet G, et al. Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital tract secretions of clinically asymptomatic, treatment-naive African women. J Infect Dis 2003;188:549-54. (Pubitemid 37011807)
9. Spinillo A, Debiaggi M, Zara F, et al. Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women. Obstet Gynecol 2001;97:999-1004. (Pubitemid 32522501)
10. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22. (Pubitemid 13221599)
11. Spinillo A, Zara F, De Santolo A, et al. Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1- infected women. Clin Microbiol Infect 1999;5:605-11. (Pubitemid 29507414)
12. Ehrlich GD. PCR-based methods for the detection of the human Retroviridae and Hepadnaviridae. In: Ehrlich GD, Greenberg SJ, editors. PCR-based diagnostics in infectious disease. Boston (Mass): Blackwell Scientific Publications; 1994, pp. 415-46.
13. Menzo S, Bagnarelli P, Giacca M, et al. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol 1992;30:1752-7.
14. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44: 1049-60.
15. Lipsitz SR, Kim K, Zhao L. Analysis of repeated categorical data using generalized estimating equations. Stat Med 1994;13:1149-63. (Pubitemid 24191583)
16. Cu Uvin S, Caliendo AM. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women. Obstet Gynecol 1997;90:739-43.
17. Rasheed S. Infectivity and dynamics of HIV type 1 replication in the blood and reproductive tract of HIV type 1-infected women. AIDS Res Hum Retroviruses 1998;14:S105-17.
18. Heikinheimo O, Lähteenmäki P. Contraception and HIV infection in women. Hum Reprod Update 2009;15:165-76 Epub 2008 Nov 1. Review.
19. Coombs RW, Reichelderfer PS, Landay AL. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 2003;17:455-80. (Pubitemid 36293099)
20. Spinillo A, Zara F, Gardella B, et al. Cervical intraepithelial neoplasia and cervicovaginal shedding of human immunodeficiency virus. Obstet Gynecol 2006;107(2 Pt 1):314-20.
21. Spinillo A, Zara F, Gardella B, et al. The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions. Am J Obstet Gynecol 2005;192:774-9. (Pubitemid 40311269)
22. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 1998;351:5-7. (Pubitemid 128643728)
23. 23] Wright TC, Subbarao S, Ellerbrock TV, et al. Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol 2001;184:279-85. (Pubitemid 32206972)
24. Baeten JM, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis 2007;45:360-9. (Pubitemid 47101035)
25. Wang CC, Reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive pill users: a meta-analysis. J Acquir Immune Defic Syndr 1999; 21:51-8. (Pubitemid 29214324)
26. Hel Z, Stringer E, Mestecky J. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. End Rev 2010;31:79-97.
27. Smith SM, Baskin GB, Marx PA. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis 2000;182: 708-15.
28. Wang CC, McClelland RS, Overbaugh J, et al. The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 2004;18: 205-9. (Pubitemid 38253442)
29. Cejtin HE, Jacobson L, Springer G, et al. Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women. AIDS 2003;17:1702-4.
30. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission in 563 stable couples. BMJ 1992;304:809-13.